Form 4: ANI Pharmaceuticals Executive Marken James G. Reports Stock Transaction
SEC Form 4 Filing
ANI Pharmaceuticals SVP Marken James G. reports disposition of shares for tax purposes following vesting of restricted stock.
Summary
- On April 10, 2024, Marken James G., SVP OPS & PROD DEV at ANI Pharmaceuticals, reported a transaction involving the disposition of 2,799 shares of common stock.
- The shares were withheld for tax purposes in connection with the vesting of 6,137 shares of restricted stock.
- The transaction was exempt under Rule 16(b)-3.
- Following the transaction, Marken James G. beneficially owns 116,006 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in the pharmaceutical industry.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard tax-related stock disposition.
Key Dates
| Date | Description |
|---|---|
| 04/10/2024 | Date of stock transaction (disposition of shares). |
| 04/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.